SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-093759
Filing Date
2017-03-23
Accepted
2017-03-23 16:37:07
Documents
76
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d313525d10k.htm 10-K 951793
2 EX-10.19 d313525dex1019.htm EX-10.19 4356
3 EX-10.27 d313525dex1027.htm EX-10.27 281335
4 EX-10.28 d313525dex1028.htm EX-10.28 17644
5 EX-23.1 d313525dex231.htm EX-23.1 1938
6 EX-31.1 d313525dex311.htm EX-31.1 6426
7 EX-31.2 d313525dex312.htm EX-31.2 6401
8 EX-32.1 d313525dex321.htm EX-32.1 4932
  Complete submission text file 0001193125-17-093759.txt   5485265

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT cbay-20161231.xml EX-101.INS 934578
10 XBRL TAXONOMY EXTENSION SCHEMA cbay-20161231.xsd EX-101.SCH 53242
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20161231_cal.xml EX-101.CAL 69224
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20161231_def.xml EX-101.DEF 219417
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20161231_lab.xml EX-101.LAB 486627
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20161231_pre.xml EX-101.PRE 355575
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36500 | Film No.: 17710108
SIC: 2834 Pharmaceutical Preparations